Target intelligence / Profile preview

Lysine-specific demethylase 5C (KDM5C)

Target
KDM5C
Molecular classification
Enzyme, Histone-modifying enzyme, Oxidoreductase (2-oxoglutarate and Fe(II)-dependent dioxygenase), Chromatin modifier, Epigenetic regulator
01

Overview

Lysine-specific demethylase 5C (KDM5C) is an epigenetic enzyme of the JmjC domain-containing family that specifically demethylates tri- and di-methylated lysine 4 on histone H3 (H3K4me2/3), a marker of transcriptionally active chromatin[1][6]. KDM5C thereby plays a central role in transcriptional regulation by coordinating chromatin structure and gene expression dynamics during development, differentiation, mitochondrial metabolism, and immune function[1][3][5]. The enzyme is part of larger chromatin-modifying complexes and interacts with histone deacetylases, contributing to transcriptional repression and activation in a context-dependent manner[1][4]. Dysregulation or mutation of KDM5C is implicated in various cancers, neurological disorders, immune defects, and reproductive abnormalities such as recurrent miscarriage[2][5][7]. KDM5C is actively investigated as a therapeutic target, particularly in cancer and epigenetic therapy[1][2][3].

Other names
DXS1272EJARID1CSMCXXE169Histone demethylase JARID1CJumonji/ARID domain-containing protein 1CProtein SmcXProtein Xe169[histone H3]-trimethyl-L-lysine(4) demethylase 5CJmjC domain-containing protein SMCXMRX13MRXJMRXS16MRXSCJMRXSJSmcx homolog, X chromosomeSmcy homolog, X-linked
02

Mechanism of action

Inhibition of H3K4 demethylase activity, leading to increased H3K4 methylation and altered gene expression - Transcriptional reprogramming via modification of chromatin state

03

Biological functions

Histone demethylation (specifically H3K4me1/2/3)Epigenetic regulation of gene expressionTranscriptional repression and activation (context-dependent)Cell differentiationCell proliferation controlMitochondrial metabolism regulationImmune cell (dendritic cell) population and function control
04

Disease associations

Cancer (various types including leukemia, clear cell renal cell carcinoma, breast cancer)Neurological disordersImmune function dysregulation (including altered dendritic cell function)Reproductive disorders (e.g., recurrent miscarriage)
05

Safety considerations

On-target toxicities due to global epigenetic changesPotential effects on cell proliferation, differentiation, and immune functionPossible reproductive and developmental effects based on role in placenta and early developmentRisks of dedifferentiation, impaired immune response, or off-target transcriptional effects
06

Interacting drugs

Histone lysine demethylase inhibitors (e.g., KDM5-specific inhibitors; no approved drug names appear in results, but small-molecule inhibitors that target KDM5 family are under investigation)

2 more in the full profile.

07

Biomarkers

Mutational status of KDM5C in cancer and neurological diseaseKDM5C expression in tumor or placental tissue (prognostic or predictive relevance in AML, reproductive disorders)H3K4 methylation levels (as a pharmacodynamic marker)KDM5C mRNA/protein levels for risk stratification in AMLPotential immune cell phenotypes (dendritic cell subsets, inflammatory profiles)

Beyond the preview

Go deeper on Lysine-specific demethylase 5C (KDM5C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysine-specific demethylase 5C (KDM5C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call